Massimo Salvetti
Impact in
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Cardiovascular Function and Risk Factors
- Renin-Angiotensin System Studies
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Blood Pressure and Hypertension Studies 76
- Cardiovascular Health and Disease Prevention 55
- Cardiovascular Function and Risk Factors 24
- Renin-Angiotensin System Studies 9
- Nephrology 26
- Gout, Hyperuricemia, Uric Acid 23
- Co-authors
- María Lorenza Muiesan (139 shared papers)Damiano Rizzoni (57 shared papers)Enrico Agabiti‐Rosei (35 shared papers)Maurizio Castellano (37 shared papers)Anna Paini (89 shared papers)Enrico Agabiti Rosei (54 shared papers)Cristina Monteduro (27 shared papers)Enzo Porteri (27 shared papers)
- Journals
- Journal of Hypertension (57 papers)Hypertension (14 papers)The Lancet (8 papers)Blood Pressure (8 papers)Internal and Emergency Medicine (6 papers)
- Partner nations
- ItalyUnited KingdomSwitzerland
In The Last Decade
Massimo Salvetti
232 papers receiving 24.2k citations
Massimo Salvetti's Hit Papers
Peers
Comparison fields: 5 of 186
- Cardiology and Cardiovascular Medicine 7.3k
- Endocrinology, Diabetes and Metabolism 3.1k
- Nephrology 1.3k
- Public Health, Environmental and Occupational Health 3.8k
- Nutrition and Dietetics 1.1k
Countries citing papers authored by Massimo Salvetti
This map shows the geographic impact of Massimo Salvetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Salvetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Salvetti more than expected).
Fields of papers citing papers by Massimo Salvetti
This network shows the impact of papers produced by Massimo Salvetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Salvetti. The network helps show where Massimo Salvetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Salvetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 244 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults Hit paper breakdown → | 2017 | 5965 |
| 2 | Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants Hit paper breakdown → | 2016 | 3077 |
| 3 | Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Hit paper breakdown → | 2021 | 2568 |
| 4 | Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants Hit paper breakdown → | 2016 | 1831 |
| 5 | Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults Hit paper breakdown → | 2024 | 1305 |
| 6 | 2020 | 611 | |
| 7 | Rising rural body-mass index is the main driver of the global obesity epidemic in adults Hit paper breakdown → | 2019 | 557 |
| 8 | Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants Hit paper breakdown → | 2024 | 516 |
| 9 | 2020 | 319 | |
| 10 | Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants Hit paper breakdown → | 2020 | 311 |
| 11 | 1995 | 284 | |
| 12 | 2001 | 282 | |
| 13 | 2004 | 276 | |
| 14 | Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Hit paper breakdown → | 2022 | 249 |
| 15 | 2019 | 234 | |
| 16 | Repositioning of the global epicentre of non-optimal cholesterol Hit paper breakdown → | 2020 | 223 |
| 17 | 2015 | 212 | |
| 18 | 2003 | 164 | |
| 19 | 2003 | 162 | |
| 20 | 2015 | 159 |
About Massimo Salvetti
Massimo Salvetti is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Endocrinology, Diabetes and Metabolism, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 244 papers that have together received 25k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (76 papers), Cardiovascular Health and Disease Prevention (55 papers), Cardiovascular Function and Risk Factors (24 papers), Gout, Hyperuricemia, Uric Acid (23 papers), COVID-19 Clinical Research Studies (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Renin-Angiotensin System Studies (9 papers) and Obesity, Physical Activity, Diet (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.3k citations), Endocrinology, Diabetes and Metabolism (3.1k citations), Nephrology (1.3k citations), Public Health, Environmental and Occupational Health (3.8k citations) and Nutrition and Dietetics (1.1k citations). Massimo Salvetti has collaborated with scholars based in Italy, United Kingdom and Switzerland. Frequent co-authors include María Lorenza Muiesan, Damiano Rizzoni, Enrico Agabiti‐Rosei, Maurizio Castellano, Anna Paini, Enrico Agabiti Rosei, Cristina Monteduro, Enzo Porteri, Claudia Agabiti Rosei and Roberto Zulli. Their work appears in journals such as Journal of Hypertension, Hypertension, The Lancet, Blood Pressure and Internal and Emergency Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.